Sernova
London
About Sernova
Sernova Corp., a health sciences company, focuses on the development and commercialization of medical technologies in the United States and Canada. Its proprietary platform technologies include Cell Pouch System, a device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. The company also focuses to commercialize products for the treatment of Parkinson’s, spinal cord injury, and haemophilia diseases. Sernova Corp. is headquartered in London, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $27.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: cve:SVA
- Website: sernova.com
- Phone: 1-877-299-4603
Industries & Categories
Biotechnology, Developer Platform, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sernova-180726 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.